Stock News Releases and Press Releases OTCMKTS, NASDAQ and NYSE Markets

2024-07-01 07:30:05 ET Raymond James analyst issues OUTPERFORM recommendation for AXGN on July 1, 2024 05:51AM ET. AXGN was trading at $7.24 at issue of the analyst recommendation. Historical Analyst Recommendations Latest 10 recommendations

Sandvik wins major order to mine in Southeast Asia PR Newswire STOCKHOLM , July 1, 2024 /PRNewswire/ -- Sandvik will deliver a fleet of intelligent underground drills to a mining customer in Southeast Asia . The order is valued at approximately SEK 500 ...

2024-07-01 07:15:00 ET One thing you can say about Cathie Wood is that she's persistent. The aggressive growth investor who's also the co-founder, CEO, and ace stock picker at Ark Invest enjoys swinging the fences. She's also not afraid to go for the safe single, binge-buying some of her fa...

Similarweb Ltd. (NYSE: SMWB), a leading digital intelligence company, announced today its acquisition of 42matters, a prominent app intelligence provider headquartered in Zurich, Switzerland. The acquisition marks a significant step in expanding Similarweb’s data capabilities in the rapidl...

USANA Executive Chairman Kevin Guest Encourages Connections with July's "Social Wellness Month" Canada NewsWire SALT LAKE CITY , July 1, 2024 /CNW/ -- Throughout July, Kevin Guest , executive chairman at USANA Health Sciences (NYSE:USNA), is emphasizing boost...

2024-07-01 07:11:38 ET Investors usually don't flock to technology stocks for dividend income as these companies often dedicate their resources to growth rather than rewarding shareholders. But some of today's tech winners, though not the biggest dividend stocks out there, still offer this ...

Herbalife Ltd. (NYSE: HLF), a premier health and wellness company, community and platform, will release its second quarter 2024 financial results after the close of trading on the NYSE on Wednesday, July 31, 2024. On the same day, at 5:30 p.m. ET (2:30 p.m. PT), Herbalife’s senior manageme...

~ Proposed divestiture streamlines uniQure’s focus and represents an important milestone in its ongoing effort to significantly reduce operating expenses ~ ~ Genezen to manufacture global commercial supply of HEMGENIX ® and support uniQure’s pipeline progr...

Genezen to Acquire uniQure's Commercial Gene Therapy Manufacturing Operations in Lexington, MA PR Newswire Strategic acquisition will enable Genezen to deliver late-phase and commercial gene therapy development and manufacturing services to customers around the world. ...

Report Highlights Accomplishments of CyberArk’s Continued Efforts To Build a Diverse, Equitable and Sustainable Organization CyberArk (NASDAQ: CYBR ), the identity security company, today announced the release of its latest Environmental, Social and Governance (ESG) r...